blog.onespotallergy.com
Score (What’s this?)
Perlu Network score measures the extent of a member’s network on Perlu based on their connections, Packs, and Collab activity.
A new way to get the representation you need. Because separation is NOT a Do It Yourself Project.
The way the recalls and shortages have rolled out reminds me of when you find the beach you normally go to open, but the one right down the shoreline has been inspected and is closed due to E. coli contamination. To explain, the EpiPen shortage exists because in 2017 the FDA inspected Meridian Medical Technologies (the company owned by Pfizer that manufactures EpiPens) and found that due to violations of good manufacturing processes, they were producing adulterated products. If you’re lucky enough to live in the United States, you have access to Auvi-Q, which I think is the best product for a few reasons. Although you hold the Auvi-Q in place for five seconds, the needle leaves your body within a fraction of one second, again causing less tissue damage than an EpiPen, which requires you to hold the extended needle in your leg for five seconds.
I was contacted yesterday by Huffington Post Canada editor Natalie Stechyson to comment about the circumstances surrounding the death of Justin Mathews, age 33 of Edmonton Alberta Canada, which comments were published here: An excellent resource for allergens in non-food products is the blog Chemurgy and Allergens. Non-food products containing other allergens such as corn, milk, soy and sesame are also considered. It is my hope that many more will now follow suit to prevent tragedies like this, that each person with food allergies or asthma will carry two EpiPens at all times, and that every person reading this article will take one hour to learn anaphylaxis first aid (you can take a course by clicking here). My hope is that as Sabrina Shannon’s death from anaphylaxis and Ryan Gibbon’s death from asthma led to greater safety for children in Ontario schools, Justin Mathew’s death will lead to greater safety for allergic individuals on the work site.
I’m very pleased to advise that Healthline has awarded my blog The Best Allergy Blogs of 2017 award. It means a lot to me that I have won this Editors’ Choice medically reviewed award every year since 2013 and that my blog is considered one of the best in the world. You’re encouragement means a lot to me. * I would love for you to share this post either by using the share buttons below, or by copying and sharing this link: http://blog.onespotallergy.com/2017/05/healthline-awards-onespot-allergy-blog-for-5th-year-in-a-row/
As I predicted, Mylan has expanded the EpiPen recall to now include additional lots distributed in the U. S. and other markets in consultation with the U.S. Food and Drug Administration (FDA). In contrast to the first recall announcement that related only to the 0.3 mg injector, this recall now impacts both the 0.3 mg and 0.15 mg strengths of EpiPen Auto-Injector. Mylan states in the press release that none of the recalled lots include the authorized generic for EpiPen Auto-Injector, which is also manufactured by Meridian Medical Technologies. http://blog.onespotallergy.com/2017/03/epipen-recall-extends-worldwide/ To read the press release regarding the expanded recall included the affected lot numbers and expiry dates, click here.